Although PAX2 is primarily expressed during embryonic development and expression is normally repressed upon terminal differentiation, PAX gene expression was frequently identified in tumor cell lines, including lymphoma, breast, ovarian, lung, and colon cancer, as well as in primary tumor tissue samples [7] and was suggested as a sensitive marker for renal neoplasms [8]. This evidence concerns the gene PAX2 and neoplasm.